Fighting the flu: The surprising power of a century-old vaccine for tuberculosis

April 09, 2024

Scholars from the Research Institute of the McGill University Health Centre (RI-MUHC) have discovered a surprising facet about a century-old vaccine for tuberculosis, Bacillus Calmette Guérin (BCG). “The immune interactions involved here can ‘train’ the lungs, which are frequently exposed to infectious agents in the environment. About McGill UniversityFounded in Montreal, Quebec, in 1821, McGill University is Canada’s top ranked medical doctoral university. McGill attracts students from over 150 countries around the world, its 12,000 international students making up 30% of the student body. Over half of McGill students claim a first language other than English, including approximately 20% of our students who say French is their mother tongue.

As Canada’s flu season collides with record strep A cases and ongoing COVID-19 concerns, a new study is shedding light on our understanding of respiratory immune responses. Scholars from the Research Institute of the McGill University Health Centre (RI-MUHC) have discovered a surprising facet about a century-old vaccine for tuberculosis, Bacillus Calmette Guérin (BCG). The study, published in the journal Nature Immunology, uncovered a previously unknown mechanism that extends the vaccine’s shield to combat influenza A virus—the most prevalent flu strain.

“The immune interactions involved here can ‘train’ the lungs, which are frequently exposed to infectious agents in the environment. If we can map out the protective immune pathways involved in the lungs, this will revolutionize our conceptual and clinical approaches in developing vaccines against infections, including emergent respiratory viruses,” explains lead author Maziar Divangahi, a pulmonary immunologist, a senior scientist at the RI-MUHC, and a Professor of Medicine at McGill University. The discovery paves the way for future studies to assess whether BCG could be used to prevent other emergent viruses. Notably, research on the vaccine’s protection against COVID-19 has had promising results.

About the study

“BCG immunization induces CX3CR1hi effector memory T cells to provide cross-protection via IFN-γ-mediated trained immunity” by Kim Tran et al. was published in Nature Immunology.

About McGill University 

Founded in Montreal, Quebec, in 1821, McGill University is Canada’s top ranked medical doctoral university. McGill is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning three campuses, 12 faculties, 14 professional schools, 300 programs of study and over 39,000 students, including more than 10,400 graduate students. McGill attracts students from over 150 countries around the world, its 12,000 international students making up 30% of the student body. Over half of McGill students claim a first language other than English, including approximately 20% of our students who say French is their mother tongue. 

The source of this news is from Mc Gill University

Popular in Research

1

Apr 20, 2024

How early-stage cancer cells hide from the immune system

2

Apr 20, 2024

Three Lincoln Laboratory inventions named IEEE Milestones

3

Apr 20, 2024

Low-Cost Liquid Tames Tooth Decay

4

6 days ago

NYU to Host Zaheer Ali at the Annual Liberal Studies Student Research Colloquium—April 5

5

Apr 19, 2024

Power when the sun doesn’t shine

How Did 2020 Change Us? NYU Sociologist Eric Klinenberg Tackles the First COVID Year

1 day ago

Tornadoes kill 4 in Oklahoma, leaving trail of destruction and thousands without power

1 day ago

Surging Gasoline Prices Add Inflation Risk in US Election Year

3 days ago

Silence broken on gender pay gaps but we must hold organisations to account

Apr 17, 2024

Study of 5.8 Million Americans Finds that a College Degree Yields a Significant Return on Investment

17 hours ago

Boosting student engagement and workforce development in microelectronics

19 hours ago